Risultati per: Valutazione e gestione del Melanoma

New England Journal of Medicine, Volume 388, Issue 9, Page 859-860, March 2023.

New England Journal of Medicine, Volume 388, Issue 9, Page 813-823, March 2023.

This cohort study examines the association between tumor-infiltrating lymphocyte classification and disease progression among patients with metastatic primary cutaneous melanoma receiving checkpoint inhibitor therapy.

This randomized clinical trial examines quality of life in patients with resected melanoma at high risk for relapse who were treated with adjuvant pembrolizumab vs standard of care with either ipilimumab or high-dose interferon α 2b.

Terapie personalizzate, più efficaci in base al tipo di malattia